Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: Safety, tolerability and immunogenicity

Pediatric Infectious Disease Journal

Volumn 23, Issue 3, 2004, Pages 240-245

  Hesley, Teresa M ^a   Reisinger, Keith S ^b   Sullivan, Bradley J ^c   Jensen, Erin H ^a   Stasiorowski, Susan ^a   Meechan, Cathy D ^a   Chan, Christina Y ^a   West, David J ^d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Pittsburgh Environ Res Lab Inc   (United States)

^c MARSHFIELD CLINIC   (United States)

^d Vaccine Development and Evaluation   (United States)

Author keywords

Concomitant vaccination; Pediatric vaccines; Vaccine interactions

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE;

ANOREXIA; ANTIBODY RESPONSE; ARTICLE; CHICKENPOX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIAPER DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOGENICITY; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VIRUS; MULTICENTER STUDY; MUMPS; MUMPS VIRUS; NOSE CONGESTION; OTALGIA; OTITIS; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHINORRHEA; RUBELLA; RUBELLA VIRUS; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VIRUS INFECTION; VOMITING;

ANTIBODIES, VIRAL; CHICKENPOX VACCINE; FEMALE; HAEMOPHILUS INFLUENZAE; HEPATITIS B VACCINES; HUMANS; INFANT; INFLUENZA VACCINES; MALE; MEASLES-MUMPS-RUBELLA VACCINE; VACCINES, COMBINED; VIRAL VACCINES;

EID: 1542723746     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000114902.84651.02     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention. Recommended childhood immunization schedule: United States, 2002. MMWR 2002;51:31-3.
2. Vella PP, Staub JM, Armstrong J., et al. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB®). Pediatrics 1990;85(Suppl):668-75.
3. Shehab ZM, Brunell PA, Cobb E. Epidemiological standardization of a test for susceptibility to mumps. J Infect Dis 1984;149:810-12.
4. Wasmuth EH, Miller WJ. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol 1990;32:189-93.
5. Käyhty H, Peltola H, Karanko V, Mäkelä H. the protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
6. Anderson P. The protective level of serum antibodies to the polysaccharide of Haemophilus influenzae type b. J Infect Dis 1984;149:1034-5.
7. Robbins JB, Parke JC Jr, Schneerson R, Whisnant JK. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res 1973;7:103-10.
8. Szmuness W, Stevens CE, Zang EA, et al. A controlled trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1981;1:377-85.
9. Francis DP, Hadler SC, Thompson SE, et al. The prevention of hepatitis B with vaccine: report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Ann Intern Med 1982;97:362-6.
10. Coutinho RA, Lelie N, Albrecht-Van Lent P, et al. Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. Br Med J 1983;286:1305-8.
11. White CJ, Kuter BJ, Ngai A, et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J 1992;11:19-23.
12. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypotheses of non-zero risk difference or non-unity relative risk. Stat Med 1990;9:1447-54.
13. West DJ, Hesley TM, Jonas LC, et al. Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Pediatr Infect Dis J 1997;16:593-9.
14. White CJ, Stinson D, Staehle B, et al. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Clin Infect Dis 1997;24:925-31.
15. Shinefield HR, Black SB, Staehle BO, et al. Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R® II, VARIVAX® and Tetramune® in healthy children vs. concomitant injections of M-M-R® II and Tetramune® followed six weeks later by Varivax®. Pediatr Infect Dis 1998;17:980-5.
16. West DJ, Boslego JW, Mendelman PM, Reisinger K, Keyserling H. Concurrent administration of routine pediatric vaccines with COMVAX™ [Haemophilus b conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine]. Pediatr Res 1997;41(4 pt. 2):133A.
17. Reisinger K, Blatter M, Sullivan B, et al. Concomitant administration of COMVAX™ with M-M-R®II and varicella vaccine [Poster P33]. Presented at the Third Annual Conference on Vaccine Research sponsored by the National Foundation for Infectious Diseases, Washington, DC, April 30 to May 2, 2000.